Cristina Rubín de Célix

11PUBLICATIONS
73CO-AUTHORS
Liquid biopsiesAdditive manufacturingBehavioural epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 24, 2026
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.

Francisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet

|Sep 17, 2025
Editorial: Managing the Moving Target-Dose Adjustments in Inflammatory Bowel Disease. Authors' Reply.

Cristina Rubín de Célix, María Chaparro, Javier P Gisbert

|Aug 08, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.

Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz

|May 03, 2025
Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU.

María José Casanova, Cristina Rubín de Célix, Sabino Riestra

|Jan 08, 2025
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU.

L Madero-Velázquez, A Mínguez, L Mayorga

|Nov 14, 2023
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation.

Montse Baldan-Martin, Cristina Rubín de Célix, Macarena Orejudo

Pageof 2

Frequent Collaborators

9 joint publications

María Chaparro

9 joint publications

Javier P Gisbert

5 joint publications

Ana Gutiérrez-Casbas

4 joint publications

Manuel Barreiro-De Acosta